UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 3, 2016
(Exact name of registrant as specified in its charter)
|
Delaware
|
0-21121
|
06-1456680
|
|
(State or other jurisdiction of incorporation)
|
(Commission file number)
|
(I.R.S. employer identification no.)
|
|
One Hamden Center
|
|
|
2319 Whitney Ave, Suite 3B, Hamden, CT
|
06518
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (203) 859-6800
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
The following information is being furnished pursuant to Item 2.02 “Results of Operations and Financial Condition” of Form 8-K. Such information, including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
On March 3, 2016, TransAct issued a press release announcing its financial results for the quarter ended December 31, 2015. A copy of the press release is furnished as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits:
|
Exhibit
|
Description
|
|
|
99.1
|
Press Release dated March 3, 2016 of TransAct Technologies Incorporated
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
TRANSACT TECHNOLOGIES INCORPORATED
|
||||
|
By:
|
/s/Steven A. DeMartino
|
|||
|
Steven A. DeMartino
|
||||
|
President, Chief Financial Officer, Treasurer and Secretary
|
||||
Date: March 3, 2016
Exhibit 99.1
TRANSACT TECHNOLOGIES REPORTS 2015 FOURTH QUARTER
AND FULL YEAR RESULTS
|
-
|
Reports 2015 Fourth Quarter Revenue of $12.1 Million and $0.07 GAAP Diluted EPS
|
|
-
|
2015 Fourth Quarter Adjusted Diluted EPS Increases 133% to $0.07 from $0.03
|
|
-
|
2015 Full-Year Revenue Rises 12% to $59.7 Million
|
|
-
|
2015 Full-Year GAAP Diluted EPS of $0.39
|
|
-
|
Adjusted Diluted EPS for 2015 Full Year Rises to $0.54 from $0.13
|
Hamden, CT – March 3, 2016 – TransAct Technologies Incorporated (Nasdaq: TACT) (“TransAct” or the “Company”) today reported operating results for the fourth quarter and full year ended December 31, 2015 as summarized below:
Summary of 2015 Q4 and Full Year Results
(In millions, except per share and percentage data)
|
Three Months Ended
December 31,
|
Twelve Months Ended
December 31,
|
||||||||||||||
|
2015
|
2014
|
2015
|
2014
|
||||||||||||
|
Net sales
|
$ | 12.1 | $ | 12.3 | $ | 59.7 | $ | 53.1 | |||||||
|
Gross profit
|
$ | 5.0 | $ | 4.9 | $ | 25.0 | $ | 21.7 | |||||||
|
Gross margin
|
41.5% | 39.9% | 41.9% | 40.9% | |||||||||||
|
Operating income (loss)
|
$ | 0.5 | $ | (4.8) | $ | 4.5 | $ | (3.8) | |||||||
|
EBITDA(1)
|
$ | 0.8 | $ | (4.5) | $ | 5.9 | $ | (2.4) | |||||||
|
Net income (loss)
|
$ | 0.5 | $ | (3.0) | $ | 3.1 | $ | (2.4) | |||||||
|
Diluted earnings per share (loss)
|
$ | 0.07 | $ | (0.37) | $ | 0.39 | $ | (0.29) | |||||||
|
Adjusted operating income(2)
|
$ | 0.5 | $ | 0.2 | $ | 6.2 | $ | 1.7 | |||||||
|
Adjusted EBITDA(1)
|
$ | 0.9 | $ | 0.6 | $ | 8.1 | $ | 3.6 | |||||||
|
Adjusted net income(2)
|
$ | 0.5 | $ | 0.2 | $ | 4.2 | $ | 1.1 | |||||||
|
Adjusted diluted earnings per share(2)
|
$ | 0.07 | $ | 0.03 | $ | 0.54 | $ | 0.13 | |||||||
|
(1)
|
EBITDA is defined as net income before net interest expense, income taxes, depreciation and amortization. A reconciliation of EBITDA to net income, the most comparable Generally Accepted Accounting Principles (“GAAP”) financial measure, can be found attached to this release. Adjusted EBITDA is defined as net income before net interest expense, income taxes, depreciation, amortization and adjusted for share-based compensation and the impact of certain legal fees, settlement expenses and accrued contingent consideration as described later in this release. A reconciliation of Adjusted EBITDA to net income, the most comparable GAAP financial measure, can be found attached to this release.
|
|
(2)
|
Reconciliations of GAAP financial measures to corresponding non-GAAP financial measures can be found attached to this release.
|
Bart Shuldman, Chairman and Chief Executive Officer of TransAct, commented, “TransAct’s fourth quarter financial results again benefitted from the diversification of our product portfolio to include higher margin products that address new market opportunities. As a result, the 160 basis point improvement in fourth quarter gross margin more than offset a slight decline in net sales and led to an over two-fold increase in adjusted operating income, a 50% increase in adjusted EBITDA, and a 133% rise in adjusted diluted EPS compared to the fourth quarter of 2014. For the 2015 full year, we nearly doubled sales of our AccuDate food safety terminals and generated consistent market share gains in our domestic casino and gaming printer business. Our focus on and success with sales execution, combined with our prudent management of costs and the increase in gross margin led to a 12% increase in 2015 full year sales, solid year-over-year increases in adjusted operating income and adjusted EBITDA, and a nearly four-fold increase in adjusted net income.
“Restaurant and food service operators are increasingly recognizing the unique functionality and value proposition of our AccuDate product lineup as reflected in the consistent sales growth of our AccuDate 9700, including a substantial recent rollout with a major quick service chain operation, and growing sales of our AccuDate PRO following its introduction in May 2015. Reflecting this interest, our AccuDate terminals are generating consistent sales momentum; with sales increasing sequentially every quarter in 2015 and full year sales almost double what they were in 2014. Given this success and momentum, we continue to devote resources towards further development and innovation in our AccuDate portfolio as we focus on being the product leader in this attractive growth market by offering solutions that address opportunities across the global restaurant and foodservice industry. Our food safety terminal business is poised to generate near and long-term growth including an opportunity to add an attractive recurring revenue business component to the business line.
“In our casino and gaming business, we remain focused on the growing number of opportunities for our Epicentral promotion and bonusing system while further expanding our domestic casino printer market share. The features and reliability of our Epic® gaming printers and our commitment to the highest levels of customer support are valued by operators as reflected in the 40% year-over-year increase in domestic casino printer sales in the 2015 fourth quarter. Epicentral, an easy to use solution that allows casino operators to directly target their players by printing coupons and promotions in real-time at the gaming device, helping drive increased player visits and incremental play, is also gaining traction with casino operators. Epicentral recently went live on approximately 1,900 electronic gaming devices at Foxwoods Resort Casino as part of their new FoxPerx slot rewards program and we are delighted to aid this valued customer in their efforts to connect even more closely with their guests in order to grow their business.
“We also expect to benefit from our recent agreement to integrate Epicentral with Aristocrat’s Oasis 360 slot management system. With the technical integration now complete, we are working closely with Aristocrat’s sales team to ensure we collectively optimize their extensive reach as they begin to demonstrate the features and functionality made possible by this agreement to their large North American gaming operator customer base.”
Mr. Shuldman concluded, “TransAct has built a strong foundation for further success in 2016 and beyond based on our initiatives to diversify our product line to include new, higher-margin offerings. This strategy is already benefitting our financial results while offsetting the impact of the significant challenges in our oil and gas printer market and our decision to transition our focus away from our traditional point of sale and banking market. In 2016 we are strategically investing in our newer, high-margin AccuDate and Epicentral product lines to further grow their contribution to our overall sales mix. Furthermore, with the continued penetration of our newer products into customer opportunities around the world, we expect gross margins to reach the mid-40% level in 2016 and expect to generate another year of solid financial results.”
Review of Balance Sheet and Capital Return Initiatives
As of December 31, 2015, TransAct had approximately $4.5 million of cash and cash equivalents and no debt. During the 2015 fourth quarter, the Company paid a dividend to shareholders of $0.08 per share. Through its regular quarterly dividend and the repurchase of common stock earlier in the year, TransAct returned approximately $3.5 million to shareholders in 2015. The Company’s Board of Directors recently approved a new share repurchase plan under which TransAct is authorized to purchase up to $5 million of its outstanding shares of common stock from time to time in the open market through December 31, 2017.
Steve DeMartino, President and Chief Financial Officer of TransAct, commented, “Our 2015 sales execution, particularly for our newer products which carry higher gross margins, combined with our focus on operating expense management, were instrumental in our strong free cash flow generated in 2015. We entered 2016 with a solid financial foundation that enables TransAct to strategically invest in the high-margin AccuDate and Epicentral offerings while simultaneously returning capital to shareholders through the quarterly cash dividend and the recently authorized share repurchase program. The successful diversification of our product portfolio to address new market opportunities and our commitment to return capital to shareholders positions TransAct to drive shareholder value going forward.”
Summary of 2015 Fourth Quarter Operating Results
TransAct generated 2015 fourth quarter net sales of $12.1 million compared to net sales of $12.3 million in the 2014 fourth quarter. Food safety, point-of-sale (POS) and banking revenue increased $1.8 million, or 85%, to $4.0 million in the 2015 fourth quarter, including a 57% year-over-year increase in sales of food safety terminals as well as higher sales of the Company’s POS printer to McDonald’s. Casino and gaming revenue in the 2015 fourth quarter decreased 10% to $4.5 million compared to $5.0 million in the prior year period and was flat on a quarterly sequential basis, as a 40% year-over-year increase in domestic sales of casino printers was more than offset by a decline in international revenue. Revenue from lottery printer sales for the 2015 fourth quarter was $0.7 million, compared with $1.6 million in the 2014 fourth quarter. Printrex® revenues were $0.2 million in the 2015 fourth quarter compared to $0.9 million in the 2014 fourth quarter, and the Company’s TransAct Services Group recorded net sales of $2.7 million in the 2015 fourth quarter compared to $2.6 million in the 2104 fourth quarter.
Gross margin increased to 41.5% in the 2015 fourth quarter compared to 39.9% in the year-ago quarter, and gross profit rose slightly year over year to $5.0 million despite the lower revenue, primarily reflecting the continued shift in mix towards higher-margin products.
Total operating expenses for the 2015 fourth quarter were $4.6 million compared to $9.7 million in the year-ago quarter. Excluding $5.0 million in legal fees and settlement expenses related to the lawsuit with Avery Dennison Corporation incurred in the 2014 fourth quarter, operating expenses declined 3% year over year reflecting the Company’s successful execution of its cost reduction initiatives.
TransAct recorded operating income of $0.5 million, or 4.0% of net sales, for the 2015 fourth quarter compared to an operating loss of $4.8 million in the 2014 fourth quarter. Adjusted operating income of $0.5 million in the fourth quarter of 2015 compares to adjusted operating income of $0.2 million in the year-ago quarter. Net income in the 2015 fourth quarter was $0.5 million, or $0.07 per diluted share, compared to a net loss of $3.0 million, or $(0.37) per diluted share, in the prior-year period. Adjusted net income in the fourth quarter of 2015 was $0.5 million, or $0.07 per diluted share, compared to adjusted net income of $0.2 million, or $0.03 per diluted share, in the fourth quarter of 2014.
2015 Fourth Quarter Conference Call and Webcast
TransAct is hosting a conference call and webcast today, March 3, 2016, beginning at 4:30 p.m. ET. Both the call and the webcast are open to the general public. The conference call number is 678-825-8259 (domestic or international). Please call five minutes prior to the presentation to ensure that you are connected.
Interested parties may also access the conference call live on the Internet at www.transact-tech.com (select “Investor Relations” followed by “Events & Presentations”). Approximately two hours after the call has concluded, an archived version of the webcast will be available for replay at the same location.
Non-GAAP Financial Measures
TransAct has provided adjusted non-GAAP financial measures because the Company believes that these amounts help investors and others more accurately assess the ongoing nature of TransAct's core operations. The adjusted non-GAAP measures contained in the tables included with this release exclude the effect in the applicable periods presented of certain non-GAAP adjustments. These items have been excluded from adjusted non-GAAP financial measures because management does not believe that they are representative of underlying trends in the Company's performance. Their exclusion provides investors and others with additional information to more readily assess the Company's operating results. The Company uses the non-GAAP financial measures internally to focus management on the results of the Company's core business. The presentation of this additional non-GAAP information is not considered superior to or a substitute for the financial information prepared in accordance with GAAP.
Adjusted operating income is defined as operating income adjusted for the impact of legal fees and settlement expenses related to the lawsuit with Avery Dennison Corporation and adjustments to accrued contingent consideration from the Printrex acquisition.
Adjusted net income is defined as net income adjusted for the tax-effected impact of legal fees and settlement expenses related to the lawsuit with Avery Dennison Corporation and adjustments to accrued contingent consideration from the Printrex acquisition.
Adjusted diluted earnings per share is defined as adjusted net income divided by diluted shares outstanding.
About TransAct Technologies Incorporated
TransAct Technologies Incorporated is a leader in developing and manufacturing market-specific solutions, including printers, terminals, software and other products for transaction-based and other industries. These industries include casino and gaming, lottery, food safety, banking, point-of-sale, hospitality, oil and gas, and medical and mobile. TransAct printers and products are designed from the ground up based on market-specific requirements and are sold under the AccuDate™, Ithaca®, RESPONDER, Epic®, EPICENTRAL® and Printrex® product brands. TransAct distributes its printers and terminals through OEMs, value-added resellers, selected distributors, and direct to end-users. TransAct has over 2.9 million printers and terminals installed around the world. TransAct is also committed to providing world-class printer service, spare parts, accessories and printing supplies to its worldwide installed base of products. Through its TransAct Services Group, TransAct provides a complete range of supplies and consumable items used in the printing and scanning activities of customers in the hospitality, banking, retail, gaming, government and oil and gas exploration markets. Through its webstore, http://www.transactsupplies.com, and a direct selling team, TransAct addresses the on-line demand for these products. TransAct is headquartered in Hamden, CT. For more information, please visit http://www.transact-tech.com or call 203.859.6800.
Forward-Looking Statements
Certain statements in this press release include forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology, such as "may", "will", "expect", "intend", "estimate", "anticipate", "believe" or "continue" or the negative thereof or other similar words. All forward-looking statements involve risks and uncertainties, including, but not limited to, customer acceptance and market share gains, both domestically and internationally, in the face of substantial competition from competitors that have broader lines of products and greater financial resources; our competitors introducing new products into the marketplace; our ability to successfully develop new products; our dependence on significant customers; our dependence on significant vendors; dependence on contract manufacturers for the assembly of a large portion of our products in Asia; our ability to protect intellectual property; our ability to recruit and retain quality employees as the Company grows; our dependence on third parties for sales outside the United States, including Australia, New Zealand, Europe, Latin America and Asia; the economic and political conditions in the United States, Australia, New Zealand, Europe, Latin America and Asia; marketplace acceptance of new products; risks associated with foreign operations; the availability of third-party components at reasonable prices; price wars or other significant pricing pressures affecting the Company's products in the United States or abroad; risks associated with potential future acquisitions; our new line of food safety and oil and gas products driving increased adoption by customers; and other risk factors detailed from time to time in TransAct's reports filed with the Securities and Exchange Commission. Actual results may differ materially from those discussed in, or implied by, the forward-looking statements. The forward-looking statements speak only as of the date of this release and the Company assumes no duty to update them to reflect new, changing or unanticipated events or circumstances.
# # #
Investor Contact:
|
Steve DeMartino
President and Chief Financial Officer
TransAct Technologies Incorporated
203-859-6810
|
Richard Land, Joseph Jaffoni, Jim Leahy
JCIR
212-835-8500 or tact@jcir.com
|
- Financial tables follow -
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|||||||||||||||
|
CONSOLIDATED STATEMENTS OF OPERATIONS
|
|||||||||||||||
|
(Unaudited)
|
|||||||||||||||
|
Three Months Ended
|
Twelve Months Ended
|
||||||||||||||
|
(In thousands, except per share amounts)
|
December 31,
|
December 31,
|
|||||||||||||
|
2015
|
2014
|
2015
|
2014
|
||||||||||||
|
Net sales
|
$ | 12,116 | $ | 12,296 | $ | 59,676 | $ | 53,108 | |||||||
|
Cost of sales
|
7,082 | 7,385 | 34,698 | 31,397 | |||||||||||
|
Gross profit
|
5,034 | 4,911 | 24,978 | 21,711 | |||||||||||
|
Operating expenses:
|
|||||||||||||||
|
Engineering, design and product development
|
1,105 | 868 | 3,599 | 4,302 | |||||||||||
|
Selling and marketing
|
1,746 | 1,851 | 7,806 | 7,920 | |||||||||||
|
General and administrative
|
1,702 | 1,967 | 7,367 | 7,756 | |||||||||||
|
Legal fees and settlement expenses associated
with lawsuit
|
- | 5,030 | 1,738 | 5,505 | |||||||||||
| 4,553 | 9,716 | 20,510 | 25,483 | ||||||||||||
|
Operating income (loss)
|
481 | (4,805) | 4,468 | (3,772) | |||||||||||
|
Interest and other income (expense):
|
|||||||||||||||
|
Interest, net
|
(5) | (11) | (28) | (49) | |||||||||||
|
Other, net
|
3 | (22) | 2 | (33) | |||||||||||
| (2) | (33) | (26) | (82) | ||||||||||||
|
Income (loss) before income taxes
|
479 | (4,838) | 4,442 | (3,854) | |||||||||||
|
Income tax provision (benefit)
|
(53) | (1,798) | 1,350 | (1,433) | |||||||||||
|
Net income (loss)
|
$ | 532 | $ | (3,040) | 3,092 | $ | (2,421) | ||||||||
|
Net income (loss) per common share:
|
|||||||||||||||
|
Basic
|
$ | 0.07 | $ | (0.37) | $ | 0.40 | $ | (0.29) | |||||||
|
Diluted
|
$ | 0.07 | $ | (0.37) | $ | 0.39 | $ | (0.29) | |||||||
|
Shares used in per share calculation:
|
|||||||||||||||
|
Basic
|
7,818 | 8,146 | 7,818 | 8,307 | |||||||||||
|
Diluted
|
7,931 | 8,146 | 7,854 | 8,307 | |||||||||||
|
SUPPLEMENTAL INFORMATION – SALES BY SALES UNIT:
|
|||||||||||||||
|
Three months Ended
|
Twelve Months Ended
|
||||||||||||||
|
December 31,
|
December 31,
|
||||||||||||||
|
2015
|
2014
|
2015
|
2014
|
||||||||||||
|
Food safety, point-of-sale and banking
|
$ | 3,999 | $ | 2,164 | $ | 13,029 | $ | 9,308 | |||||||
|
Casino and gaming
|
4,518 | 5,003 | 21,755 | 22,731 | |||||||||||
|
Lottery
|
701 | 1,618 | 9,468 | 4,761 | |||||||||||
|
Printrex
|
229 | 897 | 1,381 | 3,910 | |||||||||||
|
TransAct Services Group
|
2,669 | 2,614 | 14,043 | 12,398 | |||||||||||
|
Total net sales
|
$ | 12,116 | $ | 12,296 | $ | 59,676 | $ | 53,108 | |||||||
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|||||||
|
CONSOLIDATED BALANCE SHEETS
|
|||||||
|
(Unaudited)
|
|||||||
|
December 31,
|
December 31,
|
||||||
|
(In thousands)
|
2015
|
2014
|
|||||
|
Assets:
|
|||||||
|
Current assets:
|
|||||||
|
Cash and cash equivalents
|
$ | 4,473 | $ | 3,131 | |||
|
Accounts receivable, net
|
7,174 | 9,094 | |||||
|
Inventories
|
11,296 | 11,806 | |||||
|
Deferred tax assets
|
1,932 | 3,068 | |||||
|
Other current assets
|
437 | 898 | |||||
|
Total current assets
|
25,312 | 27,997 | |||||
|
Fixed assets, net
|
2,507 | 2,438 | |||||
|
Goodwill
|
2,621 | 2,621 | |||||
|
Deferred tax assets
|
1,213 | 1,068 | |||||
|
Intangible assets, net
|
888 | 1,341 | |||||
|
Other assets
|
28 | 26 | |||||
| 7,257 | 7,494 | ||||||
|
Total assets
|
$ | 32,569 | $ | 35,491 | |||
|
Liabilities and Shareholders’ Equity:
|
|||||||
|
Current liabilities:
|
|||||||
|
Accounts payable
|
$ | 2,642 | $ | 2,365 | |||
|
Accrued liabilities
|
2,838 | 3,320 | |||||
|
Income taxes payable
|
245 | 13 | |||||
|
Accrued lawsuit settlement expenses
|
- | 3,625 | |||||
|
Deferred revenue
|
604 | 313 | |||||
|
Total current liabilities
|
6,329 | 9,636 | |||||
|
Deferred revenue, net of current portion
|
77 | 64 | |||||
|
Deferred rent, net of current portion
|
189 | 172 | |||||
|
Other liabilities
|
246 | 225 | |||||
| 512 | 461 | ||||||
|
Total liabilities
|
6,841 | 10,097 | |||||
|
Shareholders’ equity:
|
|||||||
|
Common stock
|
112 | 111 | |||||
|
Additional paid-in capital
|
28,921 | 28,167 | |||||
|
Retained earnings
|
22,956 | 22,349 | |||||
|
Accumulated other comprehensive loss, net of tax
|
(80) | (72) | |||||
|
Treasury stock, at cost
|
(26,181) | (25,161) | |||||
|
Total shareholders’ equity
|
25,728 | 25,394 | |||||
|
Total liabilities and shareholders’ equity
|
$ | 32,569 | $ | 35,491 | |||
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
|
|
(Unaudited, thousands of dollars, except percentages and per share amounts)
|
|
Three months Ended
December 31, 2015
|
|||||||||||
|
Reported
|
Adjustments(1)
|
Adjusted
Non-GAAP
|
|||||||||
|
Operating expenses
|
$ | 4,553 | $ | - | $ | 4,553 | |||||
|
% of net sales
|
37.6% | 37.6% | |||||||||
|
Operating income
|
481 | - | 481 | ||||||||
|
% of net sales
|
4.0% | 4.0% | |||||||||
|
Income before income taxes
|
479 | - | 479 | ||||||||
|
Income tax provision (benefit)
|
(53) | - | (53) | ||||||||
|
Net income
|
532 | - | 532 | ||||||||
|
Diluted net income per share
|
$ | 0.07 | $ | - | $ | 0.07 | |||||
|
(1)
|
No adjustments.
|
|
|
|
Three months Ended
December 31, 2014
|
|||||||||||
|
Reported
|
Adjustments (2)
|
Adjusted
Non-GAAP
|
|||||||||
|
Operating expenses
|
$ | 9,716 | $ | (5,030) | $ | 4,686 | |||||
|
% of net sales
|
79.0% | 38.1% | |||||||||
|
Operating income (loss)
|
(4,805) | 5,030 | 225 | ||||||||
|
% of net sales
|
(39.1)% | 1.8% | |||||||||
|
Income (loss) before income taxes
|
(4,838) | 5,030 | 192 | ||||||||
|
Income tax provision (benefit)
|
(1,798) | 1,761 | (37) | ||||||||
|
Net income (loss)
|
(3,040) | 3,269 | 229 | ||||||||
|
Diluted net income (loss) per share
|
$ | (0.37) | $ | 0.40 | $ | 0.03 | |||||
|
(2)
|
Adjustment includes $5,030 of legal and settlement expenses related to the lawsuit with Avery Dennison Corporation tax effected using an effective tax rate of 35%.
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF GAAP EARNINGS FINANCIAL MEASURES TO CORRESPONDING
NON-GAAP FINANCIAL MEASURES
|
|
(Unaudited, thousands of dollars, except percentages and per share amounts)
|
|
Twelve Months Ended
December 31, 2015
|
|||||||||||
|
Reported
|
Adjustments(3)
|
Adjusted
Non-GAAP
|
|||||||||
|
Operating expenses
|
$ | 20,510 | $ | (1,738) | $ | 18,772 | |||||
|
% of net sales
|
34.4% | 31.5% | |||||||||
|
Operating income
|
4,468 | 1,738 | 6,206 | ||||||||
|
% of net sales
|
7.5% | 10.4% | |||||||||
|
Income before income taxes
|
4,442 | 1,738 | 6,180 | ||||||||
|
Income tax provision
|
1,350 | 608 | 1,958 | ||||||||
|
Net income
|
3,092 | 1,130 | 4,222 | ||||||||
|
Diluted net income per share
|
$ | 0.39 | $ | 0.15 | $ | 0.54 | |||||
|
(3)
|
Adjustments include $1,763 of legal and other expenses partially offset by a $25 reversal of accrued settlement expenses related to the lawsuit with Avery Dennison Corporation. Such adjustments were tax effected using an effective tax rate of 35%.
|
|
|
|
Twelve Months Ended
December 31, 2014
|
|||||||||||
|
Reported
|
Adjustments (4)
|
Adjusted
Non-GAAP
|
|||||||||
|
Operating expenses
|
$ | 25,483 | $ | (5,445) | $ | 20,038 | |||||
|
% of net sales
|
48.0% | 37.7% | |||||||||
|
Operating income (loss)
|
(3,772) | 5,445 | 1,673 | ||||||||
|
% of net sales
|
(7.1)% | 3.2% | |||||||||
|
Income (loss) before income taxes
|
(3,854) | 5,445 | 1,591 | ||||||||
|
Income tax provision (benefit)
|
(1,433) | 1,906 | 473 | ||||||||
|
Net income (loss)
|
(2,421) | 3,539 | 1,118 | ||||||||
|
Diluted net income (loss) per share
|
$ | (0.29) | $ | 0.42 | $ | 0.13 | |||||
|
(4)
|
Adjustment includes (i) $60 of income related to an adjustment to accrued contingent consideration from the Printrex acquisition and (ii) $5,505 of legal and settlement expenses related to the lawsuit with Avery Dennison Corporation. Such adjustments were tax effected using an effective tax rate of 35%.
|
|
TRANSACT TECHNOLOGIES INCORPORATED
|
|
RECONCILIATION OF NET INCOME TO ADJUSTED EBITDA
NON-GAAP FINANCIAL MEASURES
|
|
(Unaudited)
|
|
Three Months Ended
|
Twelve Months Ended
|
||||||||||||||
|
(In thousands)
|
December 31,
|
December 31,
|
|||||||||||||
|
2015
|
2014
|
2015
|
2014
|
||||||||||||
|
Net income (loss)
|
$ | 532 | $ | (3,040) | $ | 3,092 | $ | (2,421) | |||||||
|
Interest (income) expense, net
|
5 | 11 | 28 | 49 | |||||||||||
|
Income tax provision (benefit)
|
(53) | (1,798) | 1,350 | (1,433) | |||||||||||
|
Depreciation and amortization
|
349 | 361 | 1,426 | 1,445 | |||||||||||
|
EBITDA
|
833 | (4,466) | 5,896 | (2,360) | |||||||||||
|
Share-based compensation expense
|
111 | 64 | 488 | 506 | |||||||||||
|
Legal fees and settlement expenses associated
with lawsuit
|
- | 5,030 | 1,738 | 5,505 | |||||||||||
|
Adjustment to accrued contingent consideration
|
- | - | - | (60) | |||||||||||
|
Adjusted EBITDA
|
$ | 944 | $ | 628 | $ | 8,122 | $ | 3,591 | |||||||